Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD7 (clone 3A1G). We employs the pAS (T7-BFP-IL-10-EcoRI) vector components and the SynExpress system of the Coding regions Deletion/Positive feedback for a robust and sustained response against cancers.
Host
Human
Target
CD7
Clone
3A1G
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
BFP
Promoter
T7
Effector Gene
IL-10
Insertion Sites
EcoRI
Gene Modification
Deletion
Modification Domain
Coding regions
Carrier Type
pAS
Transformation Accuracy
0.96
Cell Culture
3D Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.